The influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: The comparison with IGF-I effect

Journal of Endocrinological Investigation

Volumn 37, Issue 3, 2014, Pages 233-245

  Grabiec, K ^a   Gajewska, M ^a   Milewska, M ^a   Blaszczyk M ^a   Grzelkowska Kowalczyk, K ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

G1cyclins; High glucose and insulin; IGF I; Myogenesis

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE; GLUCOSE; INSULIN; PROTEIN P21; SOMATOMEDIN C; ANTIDIABETIC AGENT; SWEETENING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HYPOGLYCEMIC AGENTS; IMMUNOPRECIPITATION; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MYOBLASTS; SWEETENING AGENTS;

EID: 84900550953     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-013-0007-z     Document Type: Article

References (36)

1. Zhu MJ, Ford SP, Means WJ, Hess BW, Nathanielsz PW, Du MJ (2006) Maternal nutrient restriction affects properties of skeletal muscle in offspring. J Physiol 575:241-250
2. Karalaki M, Fili S, Philippou A, Koutsilieris M (2009) Muscle regeneration: cellular and molecular events. In Vivo 23:779-796
3. Tong JF, Xu Y, Zhu MJ, Ford SP, Nathanielsz PW, Du M (2009) Maternal obesity downregulates myogenesis and β-catenin signaling in fetal skeletal muscle. Am J Physiol Endocrinol Metab 296:E917-E924
4. Du M, Yan X, Tong JF, Zhao J, Zhu MJ (2010) Maternal obesity, inflammation, and fetal skeletal muscle development. Biol Reprod 82:4-12
5. Oak SA, Tran C, Pan G, Thamotharan M, Devaskar SU (2006) Perturbed skeletal muscle insulin signalling in the adult female intrauterine growth restricted rat. Am J Physiol Endocrinol Metab 290:E1321-E1330
6. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387
7. Warner MJ, Ozanne SE (2010) Mechanisms involved in the developmental programming of adulthood disease. Biochem J 427:333-347
8. Floyd ZE, Trausch-Azar JS, Reinstein E, Ciechanover A, Schwartz AL (2001) The nuclear ubiquitin-proteasome system degrades MyoD. J Biol Chem 276:22468-22475
9. Blomen VA, Boonstra J (2007) Cell fate determination during G1 phase progression. Cell Mol Life Sci 64:3084-3104
10. Saab R, Bills JL, Miceli AP et al (2006) Pharmacologic inhibition of cyclin-dependent-kinase 4/6 activity arrests proliferation in myoblasts and rhabdosarcoma-derived cells. Mol Cancer Ther 5:1299-1308
11. Shiomi K, Kiyono T, Okamura K et al (2011) CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential. Gene Ther 9:857-866
12. Dahlman JM, Wang J, Bakkar N, Guttridge DC (2009) The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for the cell cycle withdrawal and skeletal myogenesis. J Cell Biochem 106:42-51
13. Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14:159-169
14. Ren B, Cam H, Takahashi Y et al (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16:245-256
15. Ishido M, Kami K, Masuhara M (2004) In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol Cell Physiol 287:C484-C493
16. Gurung R, Parnaik VK (2012) Cyclin D3 promotes myogenic differentiation and Pax7. J Cell Biochem 113:209-219
17. De Santa F, Albini S, Mezzaroma E, Baron L, Felsani A, Caruso M (2007) pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation. Mol Cell Biol 27:7248-7265
18. Huh MS, Parker MH, Scimè A, Parks R, Rudnicki MA (2004) Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. Cell Biol 13:865-876
19. Grzelkowska-Kowalczyk K, Wieteska-Skrzeczyńska W, Grabiec K, Tokarska J (2013) High glucose-mediated alterations of the mechanisms important for myogenesis of mouse C2C12 myoblasts. Cell Biol Int 37:29-35
20. Paul AC, Rosenthal N (2002) Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol 156:751-760
21. Iresjö B-M, Svensson J, Ohlsson C, Lundholm K (2013) Liver-deriver endocrine IGF-I is not sufficient for activation of skeletal muscle protein synthesis following oral feeding. BMC Physiol 13:7
22. rsk in mouse C2C12 myogenic cells exposed to high glucose and high insulin. Pol J Vet Sci 3:241-250
23. Wieteska-Skrzeczyńska W, Grzelkowska-Kowalczyk K, Tokarska J, Grabiec K (2011) Growth factor and cytokine interactions In myogenesis. Part I. The effect of TNF-alpha and IFN-gamma on IGF-I-dependent differentiation in mouse C2C12 myogenic cells. Pol J Vet Sci 14:417-424
24. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 8:328-336
25. Gaboardi GC, Ramazzotti G, Bavelloni A et al (2010) A role for PKCepsilon during myogenic differentiation. Cell Signal 22:629-635
26. Nedachi T, Kadotani A, Ariga M, Katagiri H, Kanzaki M (2008) Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes. Am J Physiol Endocrinol Metab 294:E668-E678
27. De Falco M, De Luca A (2006) Involvement of cdks and cyclins in muscle differentiation. Eur J Histochem 50:19-24
28. Yang K, Hitomi M, Stacey DW (2006) Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div 1:32
29. Kip1 acts downstream on N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation. Mol Biol Cell 16:1469-1480
30. Griffin CA, Apponi LH, Long KK, Pavlath GK (2010) Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 123:3052-3060
31. Zhang H, Hannon GJ, Beach D (1994) P-21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750-1758
32. Wei Q, Paterson BM (2001) Regulation of MyoD function in the dividing myoblast. FEBS Lett 490:171-178
33. Dupont J, LeRoith D (2001) Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. J Clin Pathol: Mol Pathol 54:149-154
34. Mouly V, Aamiri A, Bigot A et al (2005) The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 184:3-15
35. Zhang S, Rattanatray L, Morrison JL, Nicholas LM, Lie S, McMillen IC (2011) Maternal obesity and the early origins of childhood obesity: weighing up the benefits and costs of maternal weight loss in the periconceptional period for the offspring. Exp Diab Res. doi:10.1155/2011/585749
36. Bonnet M, Cassar-Malek I, Chilliard Y, Picard B (2010) Ontogenesis of muscle and adipose tissues and their interactions in ruminants and other species. Animal 4:1093-1109